Distinctions with a Difference: RNA Subtyping and Clinical Outcome in Pancreatic Cancer

Pancreatic cancer patients are in desperate need of effective therapy virtually from the moment of their diagnosis. As we acquire more therapies, how best to deploy them, in what order and to which patients is emerging as an important clinical question. Pancreatic cancer subtypes, identifiable with common lab diagnostics in diagnostic biopsy samples, may be helpful in guiding therapy selection.

See related article by O'Kane et al., p. 4901